These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Technical advances in prenatal diagnosis of tyrosinase-negative oculocutaneous albinism. Shimizu H Acta Derm Venereol; 1997 Jan; 77(1):10-3. PubMed ID: 9059668 [TBL] [Abstract][Full Text] [Related]
3. [Prenatal gene diagnosis of oculocutaneous albinism type I]. Li HY; Wu WI; Zheng H; Duan HL; Chen Z; Chen LM Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Jun; 23(3):280-2. PubMed ID: 16767664 [TBL] [Abstract][Full Text] [Related]
4. A novel mutation of the tyrosinase gene causing oculocutaneous albinism type 1 (OCA1). Nakamura E; Miyamura Y; Matsunaga J; Kano Y; Dakeishi-Hara M; Tanita M; Kono M; Tomita Y J Dermatol Sci; 2002 Feb; 28(2):102-5. PubMed ID: 11858948 [TBL] [Abstract][Full Text] [Related]
5. A nonsense mutation in the tyrosinase gene of Afghan patients with tyrosinase negative (type IA) oculocutaneous albinism. Giebel LB; Musarella MA; Spritz RA J Med Genet; 1991 Jul; 28(7):464-7. PubMed ID: 1832718 [TBL] [Abstract][Full Text] [Related]
6. DNA-based prenatal diagnosis of a Korean family with tyrosinase-related oculocutaneous albinism (OCA1). Lee ST; Park SK; Lee H; Lee JS; Park YW Jpn J Hum Genet; 1997 Dec; 42(4):499-505. PubMed ID: 9560949 [TBL] [Abstract][Full Text] [Related]
7. Prenatal diagnosis of oculocutaneous albinism by analysis of the fetal tyrosinase gene. Shimizu H; Niizeki H; Suzumori K; Aozaki R; Kawaguchi R; Hikiji K; Nishikawa T J Invest Dermatol; 1994 Jul; 103(1):104-6. PubMed ID: 8027570 [TBL] [Abstract][Full Text] [Related]
8. Prenatal molecular diagnosis of oculocutaneous albinism (OCA) in a large cohort of Israeli families. Rosenmann A; Bejarano-Achache I; Eli D; Maftsir G; Mizrahi-Meissonnier L; Blumenfeld A Prenat Diagn; 2009 Oct; 29(10):939-46. PubMed ID: 19626598 [TBL] [Abstract][Full Text] [Related]
9. Prevalent and novel mutations of the tyrosinase gene in Korean patients with tyrosinase-deficient oculocutaneous albinism. Park SK; Lee KH; Park KC; Lee JS; Spritz RA; Lee ST Mol Cells; 1997 Apr; 7(2):187-91. PubMed ID: 9163730 [TBL] [Abstract][Full Text] [Related]
10. Rapid genetic analysis of oculocutaneous albinism (OCA1) using denaturing high performance liquid chromatography (DHPLC) system. Lin SY; Chien SC; Su YN; Lee CN; Chen CP Prenat Diagn; 2006 May; 26(5):466-70. PubMed ID: 16570240 [TBL] [Abstract][Full Text] [Related]
11. [Early prenatal genetic diagnosis of oculocutaneous albinism type I in seven families]. Wu Q; Shi HR; Liu N; Lu N; Jiang M; Zhao ZH; Kong XD Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Aug; 29(4):377-81. PubMed ID: 22875490 [TBL] [Abstract][Full Text] [Related]
12. Tyrosinase gene mutations in oculocutaneous albinism 1 (OCA1): definition of the phenotype. King RA; Pietsch J; Fryer JP; Savage S; Brott MJ; Russell-Eggitt I; Summers CG; Oetting WS Hum Genet; 2003 Nov; 113(6):502-13. PubMed ID: 13680365 [TBL] [Abstract][Full Text] [Related]
13. Molecular bases of tyrosinase-negative oculocutaneous albinism: a single base insertion or a missense point mutation in the tyrosinase gene. Tomita Y; Takeda A; Matsunaga J; Okinaga S; Shibahara S; Tagami H Pigment Cell Res; 1992; Suppl 2():96-100. PubMed ID: 1409445 [TBL] [Abstract][Full Text] [Related]
14. A frequent tyrosinase gene mutation in classic, tyrosinase-negative (type IA) oculocutaneous albinism. Giebel LB; Strunk KM; King RA; Hanifin JM; Spritz RA Proc Natl Acad Sci U S A; 1990 May; 87(9):3255-8. PubMed ID: 1970634 [TBL] [Abstract][Full Text] [Related]
15. A dinucleotide deletion (-delta GA115) in the tyrosinase gene responsible for type I-A (tyrosinase negative) oculocutaneous albinism in a Pakistani individual. Oetting WS; Fryer JP; King RA Hum Mol Genet; 1993 Jul; 2(7):1047-8. PubMed ID: 8364542 [No Abstract] [Full Text] [Related]
16. Electron microscopic DOPA reaction test for oculocutaneous albinism. Takizawa Y; Kato S; Matsunaga J; Aozaki R; Tomita Y; Nishikawa T; Shimizu H Arch Dermatol Res; 2000 Jun; 292(6):301-5. PubMed ID: 10929771 [TBL] [Abstract][Full Text] [Related]
17. Molecular basis of type IA (tyrosinase negative) oculocutaneous albinism. King RA; Oetting WS Pigment Cell Res; 1992; Suppl 2():249-53. PubMed ID: 1409426 [TBL] [Abstract][Full Text] [Related]
19. Sequence-based diagnosis of tyrosinase-related oculocutaneous albinism: successful sequence analysis of the tyrosinase gene from blood spots dried on filter paper. Matsunaga J; Dakeishi-Hara M; Miyamura Y; Nakamura E; Tanita M; Satomura K; Tomita Y Dermatology; 1998; 196(2):189-93. PubMed ID: 9568405 [TBL] [Abstract][Full Text] [Related]
20. Detection of 53 novel DNA variations within the tyrosinase gene and accumulation of mutations in 17 patients with albinism. Opitz S; Käsmann-Kellner B; Kaufmann M; Schwinger E; Zühlke C Hum Mutat; 2004 Jun; 23(6):630-1. PubMed ID: 15146472 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]